Patents by Inventor Damian Madan

Damian Madan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11608519
    Abstract: Embodiments disclosed herein include devices, methods, and systems for direct, selective, and sensitive detection of single-stranded and double-stranded target DNA sequences from various sources using a Cas12a protein. When activated by binding a target DNA sequence, the Cas12a cleaves a tether releasing a reporter molecule that may then be detected. In some embodiments, the systems, methods, and devices may include a filter or membrane that may help to separate the tethered and untethered reporter molecules. These devices, systems, and techniques allow a user to rapidly process samples that may contain the target DNA, without needing to amplify the target sequences. These devices and methods may be used to assay a wide variety of samples and target DNA sources, for the presence or absence of target DNA sequences. Compositions and kits, useful in practicing these methods, for example detecting a target DNA in a biological sample, are also described.
    Type: Grant
    Filed: July 30, 2018
    Date of Patent: March 21, 2023
    Assignee: Tokitae LLC
    Inventors: Ted A. Baughman, Damian Madan, Eric Nalefski, Anne-Laure M. Le Ny
  • Patent number: 11318467
    Abstract: Embodiments include assay devices within a single use, disposable cassette for biochemical assays with at least one fluid well and at least one capillary valve. The capillary valve in combination with motion of porous sheets within the assay leads to addition of liquid reagents at different times to the assay although a user adds the liquid reagents to the cassette simultaneously.
    Type: Grant
    Filed: May 29, 2020
    Date of Patent: May 3, 2022
    Assignee: Tokitae LLC
    Inventors: Caitlin E. Anderson, Joshua Davis Bishop, David Michael Cate, Benjamin David Grant, Toan Huynh, Damian Madan, Kevin Paul Flood Nichols, Bernhard Hans Weigl
  • Publication number: 20220106647
    Abstract: Embodiments disclosed herein include devices, methods, and systems for direct, selective, and sensitive detection of single-stranded and double-stranded target nucleic acid sequences from various sources in a solution-based system. When activated by binding a target nucleic acid sequence, the Cas protein cleaves a tether separating a reporter molecule from a capture moiety. The capture moiety can then be used to remove, localize, or sequester uncleaved molecule containing intact tethers. In some embodiments, the systems, methods, and devices may include a filter, a membrane, or other molecules that may help to separate the tethered and untethered reporter molecules and/or capture the reporter molecules. These devices, systems, and techniques allow a user to rapidly process samples that may contain the target nucleic acid, in some cases, without needing to amplify the target sequences, and without the need for sophisticated or expensive laboratory equipment.
    Type: Application
    Filed: February 7, 2020
    Publication date: April 7, 2022
    Applicant: Tokitae LLC
    Inventors: Ted Baughman, Anne-Laure M. Le Ny, Philip Leung, Damian Madan, Eric Nalefski
  • Publication number: 20210370290
    Abstract: Embodiments include assay devices within a single use, disposable cassette for biochemical assays with at least one fluid well and at least one capillary valve. The capillary valve in combination with motion of porous sheets within the assay leads to addition of liquid reagents at different times to the assay although a user adds the liquid reagents to the cassette simultaneously.
    Type: Application
    Filed: May 29, 2020
    Publication date: December 2, 2021
    Inventors: Caitlin E. Anderson, Joshua Davis Bishop, David Michael Cate, Benjamin David Grant, Toan Huynh, Damian Madan, Kevin Paul Flood Nichols, Bernhard Hans Weigl
  • Publication number: 20210239694
    Abstract: Generally, this disclosure relates to expression constructs that encode a reporter enzyme-affinity binding tag fusion protein that is produced after the construct is inserted into bacteriophage and the bacteriophage infects bacteria. In some embodiments, the fusion protein is captured and produces a detectable signal. Signal intensity may correlate with the number of bacterial cells in a fluid sample. Methods of detecting bacteria using the expression constructs, and microfluidic devices for detecting bacteria using the expression constructs are also disclosed.
    Type: Application
    Filed: April 19, 2019
    Publication date: August 5, 2021
    Inventors: Luis F. ALONZO, Spencer GARING, Troy HINKLEY, Anne-Laure M. LE NY, Damian MADAN, Kevin Paul Flood NICHOLS, Sam Rasmussen NUGEN
  • Publication number: 20200032325
    Abstract: Embodiments disclosed herein include devices, methods, and systems for direct, selective, and sensitive detection of single-stranded and double-stranded target DNA sequences from various sources using a programmed Cas12a protein. When activated by binding a target DNA sequence, the Cas12a cleaves a tether releasing a reporter molecule that may then be detected. In some embodiments, the systems, methods, and devices may include a filter or membrane that may help to separate the tethered and untethered reporter molecules. These devices, systems, and techniques allow a user to rapidly process samples that may contain the target DNA, without needing to amplify the target sequences. These devices and methods may be used to assay a wide variety of samples and target DNA sources, for the presence or absence of a specific target DNA sequences. Compositions and kits, useful in practicing these methods, for example detecting a target DNA in a biological sample, are also described.
    Type: Application
    Filed: July 30, 2018
    Publication date: January 30, 2020
    Inventors: Ted A. Baughman, Damian Madan, Eric Nalefski, Anne-Laure M. Le Ny
  • Publication number: 20200032324
    Abstract: Embodiments disclosed herein include devices, methods, and systems for direct, selective, and sensitive detection of single-stranded target RNA sequences from various sources using a programmed Cas13a protein. When activated by binding a target RNA sequence, the Cas13a cleaves a tether releasing a reporter molecule that may then be detected. In some embodiments, the systems, methods, and devices may include a filter or membrane that may help to separate the tethered and untethered reporter molecules. These devices, systems, and techniques allow a user to rapidly process samples that may contain the target RNA, without needing to amplify the target sequences. These devices and methods may be used to assay a wide variety of samples and target RNA sources, for the presence or absence of a specific target RNA sequence. Compositions and kits, useful in practicing these methods, for example detecting a target RNA in a biological sample, are also described.
    Type: Application
    Filed: July 30, 2018
    Publication date: January 30, 2020
    Inventors: Ted A. Baughman, James Cate, Jennifer Doudna, Gavin John Knott, Damian Madan, Eric Nalefski, Anne-Laure M. Le Ny, Brittney Thornton
  • Patent number: 10512261
    Abstract: Designs of improved canisters for animal semen straw storage in Dewars with cryogenic liquid are described. In some embodiments, the canisters include a layer of cryogen-absorbent material and an inner layer of thermally conductive material including apertures oriented and positioned to direct cryogen vapor into the interior of the container.
    Type: Grant
    Filed: February 26, 2018
    Date of Patent: December 24, 2019
    Assignee: Tokitae LLC
    Inventors: Stephen Paul Harston, Daniel Howard Lieberman, Damian Madan, Elizabeth Jane McClure, James Andrew Roecker, Shannon Weise Stone
  • Publication number: 20190324033
    Abstract: Generally, this disclosure relates to expression constructs that encode a reporter enzyme-affinity binding tag fusion protein that is produced after the construct is inserted into bacteriophage and the bacteriophage infects bacteria. In some embodiments, the fusion protein is captured and produces a detectable signal. Signal intensity may correlate with the number of bacterial cells in a fluid sample. Methods of detecting bacteria using the expression constructs, and microfluidic devices for detecting bacteria using the expression constructs are also disclosed.
    Type: Application
    Filed: April 20, 2018
    Publication date: October 24, 2019
    Inventors: Luis F. Alonzo, Anne-Laure M. Le Ny, Kevin Paul Flood Nichols, Spencer Garing, Damian Madan, Sam Rasmussen Nugen, Troy Hinkley
  • Publication number: 20180184645
    Abstract: Designs of improved canisters for animal semen straw storage in Dewars with cryogenic liquid are described. In some embodiments, the canisters include a layer of cryogen-absorbent material and an inner layer of thermally conductive material including apertures oriented and positioned to direct cryogen vapor into the interior of the container.
    Type: Application
    Filed: February 26, 2018
    Publication date: July 5, 2018
    Inventors: Stephen Paul Harston, Daniel Howard Lieberman, Damian Madan, Elizabeth Jane McClure, James Andrew Roecker, Shannon Weise Stone
  • Publication number: 20160353730
    Abstract: Designs of improved canisters for animal semen storage in Dewars are described.
    Type: Application
    Filed: February 4, 2016
    Publication date: December 8, 2016
    Inventors: Stephen Paul Harston, Daniel Howard Lieberman, Damian Madan, Elizabeth Jane McClure, James Andrew Roecker, Shannon Weise Stone
  • Patent number: 8512971
    Abstract: Fluorogenic lysophosphatidic acid derivatives which can be used as substrates in a continuous, fluorogenic assay that can be performed in microtiter plates. The assays permit measuring LysoPLD activity levels in normal events such as pregnancy or disease states such as cancer. In addition, the present invention can be adopted to high throughout screening (HTS) for identification of potential inhibitors of lysoPLD activity.
    Type: Grant
    Filed: May 12, 2010
    Date of Patent: August 20, 2013
    Assignee: Echelon Biosciences, Inc.
    Inventors: Colin Ferguson, Glenn Prestwich, Damian Madan
  • Publication number: 20100260682
    Abstract: Fluorogenic lysophosphatidic acid derivatives which can be used as substrates in a continuous, fluorogenic assay that can be performed in microtiter plates. The assays permit measuring LysoPLD activity levels in normal events such as pregnancy or disease states such as cancer. In addition, the present invention can be adopted to high throughout screening (HTS) for identification of potential inhibitors of lysoPLD activity.
    Type: Application
    Filed: May 12, 2010
    Publication date: October 14, 2010
    Applicant: Echelon Biosciences Incorporated
    Inventors: Colin Ferguson, Glenn Prestwich, Damian Madan